Aβ Oligomers and NMDA Receptors—One Target, Two Toxicities
Two new publications add to growing evidence that toxic Aβ oligomers play havoc with neurons by...
6390 RESULTS
Sort By:
Two new publications add to growing evidence that toxic Aβ oligomers play havoc with neurons by...
New York: Can Academia and Industry Work Hand-in-Glove? New York: Back to School—R and D in Academia New York: So Many Targets, So Little Time New York: Better Living Through Chemistry? New York: The Nose, Your Magic Portal? Drug Discovery for Neurodegene
This week, two independent groups of academic researchers call for more transparency in the conduct of clinical trials...
This is the final installment of our 5-part series on the Drug Discovery for Neurodegenerative Disease conference.
This is part 4 of our 5-part series on the Drug Discovery for Neurodegenerative Disease conference.
This is part 3 of our 5-part series on the Drug Discovery for Neurodegenerative Disease conference.
Peter Lorre’s Joel Cairo in <em>The Maltese Falcon</em> might have gotten it right with his gardenia-scented business card...
Alzheimer disease brings on a tendency to wander, and patients sometimes become disoriented even in the most familiar surroundings...
This is part 2 of our 5-part series on the Drug Discovery for Neurodegenerative Disease conference.
This is part 1 of our 5-part series on the Drug Discovery for Neurodegenerative Disease conference.
Synapses, those miniscule gaps across which neurons signal one another, are far from static...
Myriad genetics presented additional 24-month data from the completed follow-on study of a phase 2 trial of its experimental Alzheimer drug...
Boosting neuronal excitation with acetylcholinesterase inhibitors is one way of tackling cognitive decline in Alzheimer disease...
Two papers last week addressed related puzzles in Huntington’s and related diseases, that is, why...
Synaptic plasticity is a contest between long-term potentiation (LTP) and long-term depression (LTD), with the...
No filters selected